CNS effects of histamine H1 antagonists

被引:7
|
作者
Rihoux, JP [1 ]
Donnelly, F [1 ]
机构
[1] UCB Pharma SA, Pharma Sector, B-1070 Brussels, Belgium
来源
关键词
allergy; pharmacology; CNS; performance impairment;
D O I
10.1046/j.1365-2222.1999.0290s3143.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
An accurate evaluation of the functions of the human brain during the administration of drugs is one of the most complex tasks in medical science. In the case of H-1 antihistamines, there are many biases that can explain why the interpretation of pharmacological data and those from clinical studies can be very difficult. First of all, the allergic disease itself may modify central nervous system (CNS) functioning and effective medical treatment may accordingly influence the self-reported CNS sensations of patients. Moreover, the carefully selected populations that are enrolled both in pharmacological and clinical studies do not reflect the profile of patients who are trreated with such drugs on an everyday basis. Finally, studies of performance impairment and those relying on self-reported sensations may give different and indeed conflicting results. It may be concluded that the various pronouncements on the CNS properties of H1 antihistamines must be treated with some caution.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [21] Effects of second-generation histamine H1 receptor antagonists on the active avoidance response in rats
    Nishiga, M
    Fujii, Y
    Konishi, M
    Hossen, MA
    Kamei, C
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2003, 30 (1-2) : 60 - 63
  • [22] Effects of histamine H1 receptor antagonists on delayed spatial win-shift task in rats
    Okada, Akiko
    Kato, Akane
    Kamei, Chiaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 631 (1-3) : 24 - 27
  • [23] Histamine H1 receptor antagonists in the treatment of insomnia -: Is there a rational basis for use?
    Monti, JM
    Monti, D
    CNS DRUGS, 2000, 13 (02) : 87 - 96
  • [24] In silico binding characteristics between human histamine H1 receptor and antagonists
    Xiaojian Wang
    Qian Yang
    Minyong Li
    Dali Yin
    Qidong You
    Journal of Molecular Modeling, 2010, 16 : 1529 - 1537
  • [25] In silico binding characteristics between human histamine H1 receptor and antagonists
    Wang, Xiaojian
    Yang, Qian
    Li, Minyong
    Yin, Dali
    You, Qidong
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (09) : 1529 - 1537
  • [26] Influence of histamine H1 receptor antagonists on osteopontin production in vitro and in vivo
    Hirano, K.
    Kazuhito, A.
    Furuta, A.
    Shino, M.
    Kanai, K.
    Suzaki, H.
    ALLERGY, 2011, 66 : 660 - 661
  • [27] Enhancement of thioredoxin production by histamine H1 receptor antagonists in vitro and in vivo
    Furuta, A.
    Hirano, K.
    Kanai, K.
    Asano, K.
    Suzaki, H.
    ALLERGY, 2011, 66 : 661 - 661
  • [28] Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis
    Procopiou, Panayiotis A.
    Ford, Alison J.
    Gore, Paul M.
    Looker, Brian E.
    Hodgson, Simon T.
    Holmes, Duncan S.
    Vile, Sadie
    Clark, Kenneth L.
    Saunders, Ken A.
    Slack, Robert J.
    Rowedder, James E.
    Watts, Clarissa J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (05): : 577 - 581
  • [29] Enhancement of thioredoxin production by histamine H1 receptor antagonists in vitro and in vivo
    Mizuyoshi, T.
    Furuta, A.
    Asano, M.
    Asano, K.
    Kobayashi, H.
    ALLERGY, 2017, 72 : 192 - 192
  • [30] Seizure-modifying potential of histamine H1 antagonists: A clinical observation
    Miyata, Ippei
    Saegusa, Hirokazu
    Sakurai, Michiro
    PEDIATRICS INTERNATIONAL, 2011, 53 (05) : 706 - 708